Literature DB >> 27061190

Differences in telomere length between sporadic and familial cutaneous melanoma.

C Menin1, E Bojnik2, P Del Bianco3, L Elefanti4, K Gianesin2, S Keppel4, C Stagni2, S Mocellin5, A Vecchiato6, A De Rossi4,2.   

Abstract

BACKGROUND: Several pieces of evidence indicate that a complex relationship exists between constitutional telomere length (TL) and the risk of cutaneous melanoma. Although the general perception is that longer telomeres increase melanoma risk, some studies do not support this association. We hypothesize that discordant data are due to the characteristics of the studied populations.
OBJECTIVES: To evaluate the association of TL with familial and sporadic melanoma.
MATERIALS AND METHODS: TL was measured by multiplex quantitative polymerase chain reaction in leukocytes from 310 patients with melanoma according to familial/sporadic and single/multiple cancers and 216 age-matched controls.
RESULTS: Patients with sporadic melanoma were found to have shorter telomeres compared with those with familial melanoma. In addition, shorter telomeres, while tending to reduce the risk of familial melanoma regardless of single or multiple tumours, nearly trebled the risk of single sporadic melanoma.
CONCLUSIONS: This is the first time that TL has been correlated to opposite effects on melanoma risk according to the presence or absence of familial predisposition. Individual susceptibility to melanoma should be taken into account when assessing the role of TL as a risk factor.
© 2016 The Authors. British Journal of Dermatology published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27061190     DOI: 10.1111/bjd.14652

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  2 in total

1.  TERT promoter hotspot mutations and their relationship with TERT levels and telomere erosion in patients with head and neck squamous cell carcinoma.

Authors:  Paolo Boscolo-Rizzo; Silvia Giunco; Enrica Rampazzo; Martina Brutti; Giacomo Spinato; Anna Menegaldo; Marco Stellin; Monica Mantovani; Luigia Bandolin; Marco Rossi; Annarosa Del Mistro; Giancarlo Tirelli; Angelo Paolo Dei Tos; Angela Guerriero; Monia Niero; Maria Cristina Da Mosto; Jerry Polesel; Anita De Rossi
Journal:  J Cancer Res Clin Oncol       Date:  2020-01-20       Impact factor: 4.553

2.  TERT Promoter Mutations Differently Correlate with the Clinical Outcome of MAPK Inhibitor-Treated Melanoma Patients.

Authors:  Paola Del Bianco; Camilla Stagni; Silvia Giunco; Alessio Fabozzi; Lisa Elefanti; Stefania Pellegrini; Antonella Vecchiato; Jacopo Pigozzo; Carolina Zamuner; Anita De Rossi; Arcangela De Nicolo; Chiara Menin
Journal:  Cancers (Basel)       Date:  2020-04-11       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.